• OPEN AN ACCOUNT
Indian Indices
Sensex
77,249.89 -119.22
( -0.15%)
Global Indices
Nasdaq
53,439.07 141.06
(0.26%)
Dow Jones
7,673.94 -21.43
(-0.28%)
Hang Seng
65,802.43 274.34
(0.42%)
Nikkei 225
10,857.89 41.33
(0.38%)
Forex
USD-INR
95.63 -0.04
(-0.04%)
EUR-INR
111.66 -0.10
(-0.09%)
GBP-INR
130.46 0.10
(0.08%)
JPY-INR
0.60 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Murae Organisor Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
542724
INE060601031
1.0194564
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
2.71
38.85
EPS(TTM)
Face Value()
Div & Yield %
0.07
1
0
 

s & t corporation ltd
Fredun Pharmaceuticals standalone net profit rises 56.58% in the March 2026 quarter
May 25,2026
Net profit of Fredun Pharmaceuticals rose 56.58% to Rs 11.07 crore in the quarter ended March 2026 as against Rs 7.07 crore during the previous quarter ended March 2025. Sales rose 27.18% to Rs 210.41 crore in the quarter ended March 2026 as against Rs 165.44 crore during the previous quarter ended March 2025.

For the full year,net profit rose 59.59% to Rs 33.21 crore in the year ended March 2026 as against Rs 20.81 crore during the previous year ended March 2025. Sales rose 40.21% to Rs 633.33 crore in the year ended March 2026 as against Rs 451.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales210.41165.44 27 633.33451.71 40
OPM %13.8510.54 -14.9712.20 -
PBDT14.659.29 58 55.5032.72 70
PBT11.548.04 44 47.5928.27 68
NP11.077.07 57 33.2120.81 60